A Patient-Derived Scaffold-Based 3D Culture Platform for Head and Neck Cancer: Preserving Tumor Heterogeneity for Personalized Drug Testing
Open Access
Abstract
Head and neck cancer (HNC) is highly heterogeneous and difficult to treat, underscoring the need for rapid, patient-specific models. Standard three-dimensional (3D) cultures often lose stromal partners that influence therapy response. We developed a patient-derived system maintaining tumor cells, cancer-associated fibroblasts (CAFs), and cells undergoing partial epithelial–mesenchymal transition (pEMT) for drug sensitivity testing. Biopsies from four HNC patients were enzymatically dissociated. CAFs were directly cultured, and their conditioned medium (CAF-CM) was collected. Cryopreserved primary tumor cell suspensions were later revived, screened in five different growth media under 2D conditions, and the most heterogeneous cultures were re-embedded in 3D hydrogels with varied gel mixtures, media, and seeding geometries. Tumoroid morphology was quantified using a perimeter-based complexity index. Viability after treatment with cisplatin or Notch modulators (RIN-1, recombination signal-binding protein for immunoglobulin κ J region (RBPJ) inhibitor; FLI-06, inhibitor) was assessed by live imaging and the water-soluble tetrazolium-8 (WST-8) assay. Endothelial Cell Growth Medium 2 (ECM-2) medium alone produced compact CAF-free spheroids, whereas ECM-2 supplemented with CAF-CM generated invasive aggregates that deposited endogenous matrix. Matrigel with this medium and single-point seeding gave the highest complexity scores. Two of the three patient tumoroids were cisplatin-sensitive, and all showed significant growth inhibition with the FLI-06 Notch inhibitor, while the RBPJ inhibitor RIN-1 induced minimal change. The optimized scaffold retains tumor–stroma crosstalk and provides patient-specific drug response data within days after operation, supporting personalized treatment selection in HNC.Keywords
All Related Versions
Funding Information
- National Science Centre, Poland (UMO-2020/37/B/N24/03920, UMO-2021/41/B/NZ7/03786OPUS19)
This publication has 54 references indexed in Scilit:
- Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancerCell, 2024
- Microfluidic Platform for Generating and Releasing Patient‐Derived Cancer Organoids with Diverse Shapes: Insight into Shape‐Dependent Tumor GrowthAdvanced Materials, 2024
- The Notch inhibitor, FLI-06, increases the chemosensitivity of head and neck Squamous cell carcinoma cells to taxanes-based treatmentBiomedicine & Pharmacotherapy, 2024
- Exploring the frontiers: tumor immune microenvironment and immunotherapy in head and neck squamous cell carcinomaDiscover Oncology, 2024
- Standardization of organoid culture in cancer researchCancer Medicine, 2023
- Fabrication of Multiresponsive Magnetic Nanocomposite Double‐Network Hydrogels for Controlled Release ApplicationsSmall, 2021
- Epithelial–Mesenchymal Transition Predicts Survival in Oral Squamous Cell CarcinomaPathology and Oncology Research, 2019
- Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast CancerClinical Breast Cancer, 2018
- Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastomaBiochemical and Biophysical Research Communications, 2017
- A plea to reduce or replace fetal bovine serum in cell culture mediaCytotechnology, 2013